Botulinum Therapy for Chronic Migraine

Botulinum Therapy for Chronic Migraine

No Abstract

Bibliographic Details
Main Authors:	Chumpol Anamnart, Niphon Poungvarin
Format:	Article
Language:	English
Published:	Mahidol University 2020-04-01
Series:	Siriraj Medical Journal
Subjects:	Botulinum; Therapy; Chronic Migraine
Online Access:	https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/241002

Similar Items

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
by: Sara M. Schaefer, et al.
Published: (2015-07-01)

Chronic Migraine: How to Diagnose and Manage
by: Niphon Poungvarin
Published: (2020-04-01)

A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache
by: Young-gun Kim, et al.
Published: (2020-03-01)

Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
by: Bahram Naderinabi, et al.
Published: (2017-06-01)

Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial
by: Shehata HS, et al.
Published: (2016-10-01)

Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines
by: Lorena Dima, et al.
Published: (2019-08-01)

Botulinum Toxin in the Treatment of Headache
by: Werner J. Becker
Published: (2020-12-01)

Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis
by: Yao-Yao Chen, et al.
Published: (2021-05-01)

The Comparison of the Effects of Two Botulinum Toxin A Injection Methods, Follow the Pain and Fixed-site Fixed-dose, on Improving the Quality of Life and Headaches in Patients with Chronic Migraine: A Preliminary Randomized Clinical Trial
by: Hossein Salehi, et al.
Published: (2020-12-01)

Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents
by: Roshni Ramachandran, et al.
Published: (2015-07-01)

Calcitonin Gene–Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison
by: Jiajie Lu, et al.
Published: (2021-05-01)

Botulinum toxin type A for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial
by: Luciano Hollanda, et al.
Published: (2014-12-01)

BOTULINUM TOXIN FOR PAIN SYNDROMES
by: E. Kostenko, et al.
Published: (2018-02-01)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
by: Stephen D. Silberstein, et al.
Published: (2020-10-01)

Impact of the botulinum-A toxin on prevention of adult migraine disorders
by: Bin Shen, Lan Wang
Published: (2020-03-01)

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
by: Mariarosaria Valente, et al.
Published: (2021-05-01)

Associated Symptoms of Chronic Migraine in Children and Adolescents
by: Kroner, John
Published: (2015)

Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA
by: Enrique Martínez-Pías, et al.
Published: (2021-06-01)

OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy
by: Jason C. Ray, et al.
Published: (2021-06-01)

Hemifacial Spasm Treated with Botulinum Toxin Injection : A Ten-Year Experience at Siriraj Hospital
by: Niphon Poungvarin, et al.
Published: (2020-08-01)

Mechanisms of Botulinum Toxin Type A Action on Pain
by: Ivica Matak, et al.
Published: (2019-08-01)

Temporomandibular disorder in chronic migraine
by: N. V. Latysheva, et al.
Published: (2017-12-01)

Patent Foramen Ovale and Stroke: Coincident or Real Association?
by: Chumpol Anamnart, et al.
Published: (2020-04-01)

Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine
by: Simona Sacco, et al.
Published: (2019-02-01)

Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report
by: V. A. Golovacheva, et al.
Published: (2021-02-01)

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
by: Raffaele Ornello, et al.
Published: (2020-04-01)

Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial
by: Giovanni Mansueto, et al.
Published: (2018-10-01)

Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome
by: Chien-Hsu Chen, et al.
Published: (2019-10-01)

Stem Cells in the Treatment of Refractory Chronic Migraines
by: Alexander Mauskop, et al.
Published: (2017-06-01)

Potentialities of botulinum therapy in cosmetology
by: O. M. Kapuler
Published: (2020-12-01)

Practical issues of management of patients with chronic migraine. Recommendations from Russian experts
by: N. V. Latysheva, et al.
Published: (2015-09-01)

Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison
by: Luana Mazzacoratti Loeb, et al.

Memory and attention deficit in chronic migraine
by: N. V. Latysheva, et al.
Published: (2018-07-01)

Depression is not the only cause of cognitive impairment in chronic migraine
by: N. V. Latysheva, et al.
Published: (2019-01-01)

COMPARATIVE CLINICAL ELECTRONEUROPHYSIOLOGICAL CHARACTERISTICS OF CHRONIC MIGRAINE
by: A. A. Yakupova, et al.
Published: (2017-12-01)

Degradation of endocannabinoids in chronic migraine and medication overuse headache
by: L.M. Cupini, et al.
Published: (2008-05-01)

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials
by: Stewart J Tepper, et al.
Published: (2021-07-01)

Factors associated with acute medication overuse in chronic migraine patients
by: Vera Zukerman Guendler, et al.
Published: (2012-09-01)

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study
by: Michail Vikelis, et al.
Published: (2017-05-01)

Early onset of efficacy with erenumab in patients with episodic and chronic migraine
by: Todd Schwedt, et al.
Published: (2018-10-01)